The clearance broadens use of Omvoh, which is part of a slate of new medicines Lilly is counting on to build on its success ...
The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...
The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...
More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...
The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...
THURSDAY, Jan. 16, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for ...